Meritage Portfolio Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,167
Closed -$465K 329
2024
Q1
$465K Sell
4,167
-392
-9% -$46.7K 0.03% 252
2023
Q4
$591K Buy
4,559
+242
+6% +$33.4K 0.04% 237
2023
Q3
$704K Buy
4,317
+223
+5% +$39.2K 0.05% 211
2023
Q2
$751K Buy
4,094
+1,600
+64% +$230K 0.05% 207
2023
Q1
$332K Buy
+2,494
New +$293K 0.02% 243

Other funds holding ACLS

Meritage Portfolio Management's ACLS Position: Q2 2024 in Review

Meritage Portfolio Management sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 4,167 shares — an estimated $465K sold.

Meritage Portfolio Management first reported a position in ACLS in Q1 2023 and held it in 5 quarters. The position peaked at $751K in Q2 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

  • Meritage Portfolio Management reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
  • Meritage Portfolio Management sold 4,167 Axcelis shares in Q2 2024, an estimated $465K.
  • Meritage Portfolio Management first reported a position in Axcelis in Q1 2023 and held it in 5 quarters.
  • Meritage Portfolio Management's Axcelis position peaked at $751K in Q2 2023.
  • 392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Meritage Portfolio Management's 13F filing for Q2 2024, filed 9 Aug 2024.